skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: The acquisition of 140 Proof by Acuity Ads seems to add an important component to Acuity as well as being a very well structured deal all around. Comments? 5i plan on covering some day?
Read Answer Asked by Richard on August 15, 2016
Q: The company seems to be overpriced as they are still losing cash. They have many competitors in all their sectors. Also, IMAX just closed a huge deal with China's biggest cinema operator committing to 150 IMAX screens, which reduces available space for potential D-BOX screens. As mass market adoption of virtual reality isn't yet a sure thing, would it be safe to sell this stock and rebuy it when on a big pull back? Thanks!
Read Answer Asked by Sam on August 03, 2016
Q: Hi, Ceapro Inc has garnered a lot of attention in recent months, with mentions of Nutragena, J&J and Jennifer Anniston. Stock appeared to have settled around $1.75-$1.80, but after Mr Peter Imhof made it one of his top picks on BNN, last week, it has shot up by another 25% in 3 days. Bob Mcwhirter mentioned on BNN that co. has built a new plant and would need to grow its revenue 10X to justify market expectations priced in the stock. Could you please provide some perspective on this co. and comment if it deserves this valuation and is worth starting a small position? Thanks
Read Answer Asked by rajeev on July 25, 2016
Q: Gentlemen - Wondered if you had any thoughts on Accord Financial? Seems to fit many of your criteria. It is small, pays a nice divi which has grown, is well owned by insiders and has no analyst coverage nor raises any money. It reminds me a little of Prism Medical in that you can hold it, collect a nice dividend and wait for a potential take out down the road. Cheers.
Read Answer Asked by matthew on July 04, 2016